Related references
Note: Only part of the references are listed.Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)
Masatoshi Kudo et al.
HEPATOLOGY RESEARCH (2022)
Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma
Stijn Franssen et al.
JAMA SURGERY (2022)
Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China
Changying Shi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials
Chen Hu et al.
JAMA NETWORK OPEN (2021)
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma A Phase 2 Clinical Trial
Andrea Cercek et al.
JAMA ONCOLOGY (2020)
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley et al.
JOURNAL OF HEPATOLOGY (2020)
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau et al.
JOURNAL OF HEPATOLOGY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma
Toru Yamada et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
Mengmeng Wang et al.
CANCER MEDICINE (2018)
Emerging molecular therapeutic targets for cholangiocarcinoma
Sumera Rizvi et al.
JOURNAL OF HEPATOLOGY (2017)
Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study
Lei Yuan et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone
Ioannis T. Konstantinidis et al.
CANCER (2016)
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
Nestor F. Esnaola et al.
CANCER (2016)
Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
Ban Seok Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging
Bin Huang et al.
RADIOLOGY (2016)
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer
Mie Grunnet et al.
EUROPEAN JOURNAL OF CANCER (2015)
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
Khairuddin Memon et al.
JOURNAL OF HEPATOLOGY (2012)
Share Paper
